Monday, December 16, 2024
HomeTagsLate-Stage Development

Late-Stage Development

Moleculin Provides Annamycin AML Program Update and Outlines

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, announced preliminary results...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics